» » »

Transplant for Metabolic Disorders Fresno CA

U.S. researchers are testing a new approach in cord-blood transplants to treat genetic metabolic disorders in babies while they're still in the womb. The new method uses a small, select number of therapeutic stem cells that have been treated to speed and improve engraftment (acceptance of the transplant by the body), explained Dr. Joanne Kurtzberg, a professor of pediatrics and pathology and director of the pediatric blood and marrow transplant program at Duke University Medical Center in Durham, N.C.

Randolph Lippert, MD
(559) 435-3890
PO Box 5655
Fresno, CA
Specialties
Allergy & Immunology
Gender
Male
Education
Medical School: Finch U Of Hs/Chicago Med Sch, North Chicago Il 60664
Graduation Year: 1978

Data Provided by:
Troy A Scribner
(559) 322-0787
6741 N Willow Ave
Fresno, CA
Specialty
Allergy / Immunology

Data Provided by:
James Vincent Glaser, MD
(559) 431-6330
6057 N 1st St Ste 103
Fresno, CA
Specialties
Allergy & Immunology
Gender
Male
Education
Medical School: Loyola Univ Of Chicago Stritch Sch Of Med, Maywood Il 60153
Graduation Year: 1948

Data Provided by:
Merlyn Lloyd Price
(559) 436-4500
7471 N Fresno St
Fresno, CA
Specialty
Allergy / Immunology

Data Provided by:
A M Aminian
(559) 447-1700
7375 N Fresno St Ste 101
Fresno, CA
Specialty
Allergy / Immunology

Data Provided by:
Grace Wee Lim
(559) 244-6360
3128 E Gettysburg Ave
Fresno, CA
Specialty
Allergy / Immunology

Data Provided by:
Stacy Eui-Jung Lee, MD
(559) 225-6800
5339 N Fresno St Ste 103
Fresno, CA
Specialties
Allergy & Immunology
Gender
Female
Education
Medical School: Ewha Women'S Univ, Coll Of Med, Seoul, So Korea
Graduation Year: 1975

Data Provided by:
Peter Scamagas, MD
Fresno, CA
Specialties
Allergy & Immunology
Gender
Male
Education
Medical School: Univ Of Pa Sch Of Med, Philadelphia Pa 19104
Graduation Year: 1956

Data Provided by:
Kelvin Gin sun Lee
(559) 448-4500
7300 N Fresno St
Fresno, CA
Specialty
Allergy / Immunology

Data Provided by:
A M Aminian, MD
(559) 447-1700
7375 N Fresno St Ste 101
Fresno, CA
Specialties
Allergy & Immunology
Gender
Male
Education
Medical School: Shiraz Univ Of Med Sci, Shiraz, Iran
Graduation Year: 1976

Data Provided by:
Data Provided by:

Transplant for Metabolic Disorders

Provided By:

FRIDAY, Oct. 16 (HealthDay News) -- U.S. researchers are testing a new approach in cord-blood transplants to treat genetic metabolic disorders in babies while they're still in the womb.

The new method uses a small, select number of therapeutic stem cells that have been treated to speed and improve engraftment (acceptance of the transplant by the body), explained Dr. Joanne Kurtzberg, a professor of pediatrics and pathology and director of the pediatric blood and marrow transplant program at Duke University Medical Center in Durham, N.C.

She and her team are studying the new procedure in a pilot trial open to pregnant women at risk for having children with fatal metabolic disorders, including Krabbe disease, metachromatic leukodystrophy, Pelizaeus-Maerzbacher disease, Tay-Sachs disease and Sandoff disease.

If untreated, these metabolic disorders can lead to bone, brain and central nervous system problems, and early death, the study authors noted in a Duke news release.

Donor cells used in the study will be made by the biopharmaceutical company Aldagen, Inc, which is a partner in the trial.

In many cases, cord-blood transplants after birth have proven successful in treating inherited metabolic disorders. Transplant timing is critical, Kurtzberg stressed.

"The idea is to give the baby cord-blood stem cells from a healthy donor that have the potential to provide healthy genes that can replace the ones that aren't working properly in the baby's own cells," Kurtzberg said in the news release.

In general, the earlier the transplant, the more likely it will work. That means that performing the transplant before the baby is born is ideal, she explained.

During the procedure, donor cells are injected directly into the fetus's abdomen at 12 to 14 weeks' pregnancy. At birth, the baby will be tested to see if the donor cells are present, and if they're fixing the malfunctioning genes. If not, the baby would be eligible for conventional cord-blood stem cell transplant within a few weeks.

More information

The Nemours Foundation has more about metabolism and metabolic disorders.

SOURCE: Duke Medicine, news release, Oct. 13, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com